RDIF, Minapharm agree to produce million doses of the Sputnik V vaccine in Egypt
Thursday، 22 April 2021 - 02:01 PM
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) and Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announced an agreement to produce over 40 million doses per year of the world's first registered vaccine against COVID-19, Sputnik news agency reported.
The parties intend to commence technology transfer immediately.
The rollout of the vaccine is expected in 3Q 2021.